Market size, share and growth analysis by model types & services, technology, application and end user, across all major regions and key countries, with forecasts for 2023–2032. The competitive landscape profiles 10+ companies.
The global mice model market was valued at USD 34.55 Bn in 2023 and is projected to reach USD 56.6 Bn by 2032, growing at a CAGR of 6.75%. Europe is the largest regional market and Asia-Pacific is growing fastest.
Reports Description
Global Mice Model Market is poised for growth from 2023 to 2032, primarily driven by increasing research and development activities in the pharmaceutical and biotechnology industries. The market is anticipated to experience a CAGR of approximately 6.75% during this period. In 2022, the market is expected to be valued at USD 32.10 Billion, projected to reach USD 56.60 Billion by 2032.
Mice models are critical in scientific research, including drug development, disease modelling, and safety assessment. They are used across various applications, and different types of mice models are employed to mimic specific genetic conditions and study their effects.
Mice Model Market - Significant Growth Factors
Research and Development: Increased R&D activities in the life sciences and pharmaceutical sectors drive the demand for mice models for preclinical studies.
Pharmaceutical Industry Growth: The continuous development of new drugs and therapies requires rigorous testing, for which mice models are essential.
Disease Modeling: Mice models are used to study a wide range of diseases, offering insights into their causes and potential treatments.
Safety Assessment: Mice models are crucial in toxicity and safety assessment studies for new drugs and therapies.
Academic Research: Educational institutions and research facilities rely on mice models for various academic and scientific studies.
Mice Model Market - Mergers and Acquisitions
Charles River Laboratories' Expansion: Charles River Laboratories has expanded its mice model portfolio through acquisitions, enhancing its position in the market.
Taconic Biosciences' Strategic Collaborations: Taconic Biosciences has entered into strategic collaborations to develop and offer innovative mice models.
Creative Biolabs' Research Initiatives: Creative Biolabs is involved in research initiatives to create novel mice models for various applications.
COMPARATIVE ANALYSIS OF THE RELATED MARKET
Mice Model Market
MICE Market
Inbound Meetings Incentives Conferences and Exhibitions (MICE) Tourism Market
CAGR 6.75% (Approx)
CAGR 18.2% (Approx)
CAGR 8.2% (Approx)
US$ 56.60 billion by 2032
USD 1620.7 Billion by 2032
USD 975.5 Billion by 2032
Mice Model Market - Significant Challenges
Ethical Considerations: The use of animals in research, including mice, raises ethical concerns, necessitating strict regulations and ethical standards.
Model Validation: Ensuring that mice models accurately mimic human conditions is a challenge in preclinical research.
Research Costs: Developing and maintaining mice models can be expensive, impacting research budgets.
Evolving Regulatory Landscape: Changes in regulatory requirements for animal research can affect the use of mice models.
Model Variability: Variability in mice genetics can be a limitation in some research studies.
Report Scope
Feature of the Report
Details
Market Size in 2023
USD 34.55 Billion
Projected Market Size in 2032
USD 56.60 Billion
Market Size in 2022
USD 32.10 Billion
CAGR Growth Rate
6.75% CAGR
Base Year
2023
Forecast Period
2024-2033
Key Segment
By Model Type, Application and Region
Report Coverage
Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options
Request tailored purchasing options to fulfil your requirements for research.
Category-Wise Insights
By Model Type:
Transgenic Mice: These mice carry genes from other species and are valuable for studying gene function and regulation.
Knockout Mice: These mice have specific genes "knocked out," providing insights into gene function and disease mechanisms.
Hybrid/Congenic Mice: These mice have a mix of genetic backgrounds, useful for studying complex traits.
Conditioned/Surgically Modified Mice: These mice undergo surgical or environmental modifications to study specific conditions.
By Application:
Research & Development: Mice models are extensively used in drug discovery and development.
Safety Assessment: Toxicity and safety studies are critical in drug testing and development.
Production: Mice models are also used to produce biological products and therapies.
Academic Research: Educational institutions and research facilities employ mice models in various academic and scientific studies.
Which are the driving factors of the Mice Model Market?
The key factors driving the Market are Research and Development, Pharmaceutical Industry Growth, Disease Modeling, Safety Assessment And Academic Research.
Which type led the Mice Model market?
The "ransgenic Mice" category dominated the market in 2022.
Who are the key players in the Mice Model market?
The key players in the market are Charles River Laboratories, The Jackson Laboratory, Taconic Biosciences, Envigo, Creative Biolabs, Crown Bioscience, Horizon Discovery Group, JANVIER LABS, Laboratory Corporation of America Holdings, Transposagen Biopharmaceuticals, Others.
Which region held the largest market share in the Mice Model market?
"North America" had the largest share in the Mice Model Market.
What is the growth rate of the Mice Model market?
The global market is projected to grow at a CAGR of 6.75% during the forecast period, 2023-2032.
How much is the Mice Model market?
The Mice Model Market size was valued at USD 32.10 Billion in 2022.
Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping clients turn complex data into actionable business decisions.